$0.2900
At close: Apr 22, 5:00 PM EST
Kaleido Biosciences Earnings Estimates, EPS & Revenue | OTC:KLDO
In the most recent quarter (Q3), Kaleido Biosciences reported EPS of $-0.54, meeting estimates of $-0.54. Revenue came in at $104.00K, missing the estimate of $170.00K by 0.39%.
Over the last 2 quarters, Kaleido Biosciences has averaged an EPS surprise of 0.01% and a revenue surprise of 0.65%.
Earnings Date
Nov 1
EPS
$-0.540
Quarterly Revenue
$104.00K
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$1.10M
Kaleido Biosciences Earnings History
Analyze the earnings history of Kaleido Biosciences using advanced sorting and filters.
Loading calendar...
Kaleido Biosciences (KLDO) Earnings Per Share
The chart below shows Kaleido Biosciences's reported EPS compared to analyst estimates over recent quarters.
Kaleido Biosciences (KLDO) Revenue
The chart below shows Kaleido Biosciences's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Kaleido Biosciences (OTCEM:KLDO) reporting earnings?
Kaleido Biosciences (KLDO) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 1, 2021 for Q3.
What were the latest earnings per share (EPS) for Kaleido Biosciences (OTCEM:KLDO)?
Kaleido Biosciences (KLDO) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 1, 2021 for Q3 and the Actual EPS was $-0.54, which hit the estimate of $-0.54.
What were Kaleido Biosciences’s (OTCEM:KLDO) revenues?
Kaleido Biosciences (KLDO) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 1, 2021 for Q3 and the Actual Revenue was $104.00K, which missed the estimate of $170.00K.
